Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Savara Inc (SVRA)

Savara Inc (SVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Savara Inc 1717 LANGHORE NEWTOWN ROAD SUITE 300 LANGHORNE PA 19047 USA

www.savarapharma.com Employees: 37 P: 512-614-1848

Description:

Savara Inc. is a clinical-stage pharmaceutical company. It focused on the development and commercialization of novel therapies for the treatment of patients with rare respiratory diseases. Savara Inc., formerly known as Mast Therapeutics, Inc., is based in Austin, United States.

Key Statistics

Overview:

Market Capitalization, $K 537,168
Enterprise Value, $K 536,928
Shares Outstanding, K 171,619
Annual Sales, $ 0 K
Annual Net Income, $ -54,700 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -24,250 K
EBIT, $ -89,520 K
EBITDA, $ -94,060 K
60-Month Beta 1.02
% of Insider Shareholders 5.13%
% of Institutional Shareholders 87.93%
Float, K 162,815
% Float 94.87%
Short Volume Ratio 0.37

Growth:

1-Year Return -13.14%
3-Year Return 181.74%
5-Year Return 157.14%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 74.42%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.11 on 11/12/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -0.43
EPS Growth vs. Prev Qtr 8.33%
EPS Growth vs. Prev Year -10.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-70 on 04/28/17

SVRA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -58.89%
Return-on-Assets % -46.44%
Profit Margin % 0.00%
Debt/Equity 0.13
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.43
Book Value/Share 1.21
Interest Coverage -2.49
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar